Literature DB >> 29784709

Response to Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10.

Samy Suissa1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29784709     DOI： 10.2337/dci18-0015

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  5 in total

1.  Sodium-glucose co-transporter-2 inhibitor use and risk of lower-extremity amputation: Evolving questions, evolving answers.

Authors:  Jeff Y Yang; Tiansheng Wang; Virginia Pate; Emily W Gower; Matthew J Crowley; John B Buse; Til Stürmer
Journal:  Diabetes Obes Metab       Date:  2019-03-04       Impact factor: 6.577

2.  Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs.

Authors:  Guntram Schernthaner; Avraham Karasik; Agnė Abraitienė; Alexander S Ametov; Zsolt Gaàl; Janusz Gumprecht; Andrej Janež; Susanne Kaser; Katarina Lalić; Boris N Mankovsky; Evgeny Moshkovich; Marju Past; Martin Prázný; Gabriela Radulian; Lea Smirčić Duvnjak; Ivan Tkáč; Kārlis Trušinskis
Journal:  Cardiovasc Diabetol       Date:  2019-08-31       Impact factor: 9.951

3.  Diabetes medication regimens and patient clinical characteristics in the national patient-centered clinical research network, PCORnet.

Authors:  Katherine N Bachmann; Christianne L Roumie; Andrew D Wiese; Carlos G Grijalva; John B Buse; Robert Bradford; Emily O Zalimeni; Patricia Knoepp; Sofia Dard; Heather L Morris; William T Donahoo; Nada Fanous; Vivian Fonseca; Bonnie Katalenich; Sujung Choi; Darcy Louzao; Emily O'Brien; Megan M Cook; Russell L Rothman; Rosette J Chakkalakal
Journal:  Pharmacol Res Perspect       Date:  2020-10

4.  Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors vs. Dipeptidyl Peptidase-4 Inhibitors in Frail People With Diabetes Who Were Recently Hospitalized.

Authors:  Stephen J Wood; J Simon Bell; Dianna J Magliano; Jonathan E Shaw; Matteo Cesari; Jenni Ilomaki
Journal:  Front Pharmacol       Date:  2022-07-12       Impact factor: 5.988

Review 5.  Observational research on sodium glucose co-transporter-2 inhibitors: A real breakthrough?

Authors:  Emanuel Raschi; Elisabetta Poluzzi; Gian Paolo Fadini; Giulio Marchesini; Fabrizio De Ponti
Journal:  Diabetes Obes Metab       Date:  2018-08-14       Impact factor: 6.577
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.